Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis. (Q54189257)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis. |
scientific article |
Statements
1 reference
Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis. (English)
1 reference
Y Ishigatsubo
1 reference
M Takeno
1 reference
Y Kirino
1 reference
N Mizuki
1 reference
28 September 2015
1 reference
13
1 reference
Suppl 1
1 reference
P166-P166
1 reference
Identifiers
1 reference